Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against <i>Pseudomonas aeruginosa</i>

The inadequate eradication of pulmonary infections and chronic inflammation are significant complications in cystic fibrosis (CF) patients, who usually suffer from persistent and frequent lung infections caused by several pathogens, particularly <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>)....

Descrición completa

Detalles Bibliográficos

Principais autores:	Nouf M. Alzahrani, Rayan Y. Booq, Ahmad M. Aldossary, Abrar A. Bakr, Fahad A. Almughem, Ahmed J. Alfahad, Wijdan K. Alsharif, Somayah J. Jarallah, Waleed S. Alharbi, Samar A. Alsudir, Essam J. Alyamani, Essam A. Tawfik, Abdullah A. Alshehri
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-04-01
Series:	Pharmaceutics
Assuntos:	cystic fibrosis liposomes tobramycin innate defense regulator peptide-1018 (IDR-1018) biofilm <i>Pseudomonas aeruginosa</i>
Acceso en liña:	https://www.mdpi.com/1999-4923/14/5/960
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!